ArticleBMC women's health2024

Efficacy and safety of chemotherapy as monotherapy in patients with recurrent intermediate/high-risk factors following radical hysterectomy for stage IB-IIA cervical cancer: a single-center retrospective analysis.

Bei Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.